Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases
- 27 November 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Immunologic Research
- Vol. 60 (2-3), 226-235
- https://doi.org/10.1007/s12026-014-8597-x
Abstract
Immune thrombocytopenic purpura (ITP) is an autoimmune condition characterized by low platelet count with mucocutaneous and other bleedings. Clinical manifestations may range from spontaneous formation of purpura and petechiae, especially on the extremities, to epistaxis, bleeding at the gums or menorrhagia, any of which occur usually if the platelet count is below 20,000 per μl. A very low count may result in the spontaneous formation of hematomas in the mouth or on other mucous membranes. Fatal complications, including subarachnoid or intracerebral, lower gastrointestinal or other internal bleeding can arise due to an extremely low count. Vaccines may induce ITP by several mechanisms. Vaccine-associated autoimmunity may stem not only from the antigen-mediated responses but also from other constituents of the vaccine, such as yeast proteins, adjuvants, and preservatives diluents. The most likely is through virally induced molecular mimicry. The binding of pathogenic autoantibodies to platelet and megakaryocytes may cause thrombocytopenia by different mechanisms, such as opsonization, direct activation of complement, or apoptotic pathways. The autoantibodies hypothesis is not sufficient to explain all ITP cases: In the anti-platelet antibody-negative cases, a complementary mechanism based on T cell immune-mediated mechanism has been suggested. In particular, T cell subsets seem dysregulated with an increased production of pro-inflammatory cytokines, as IFN-γ and TNF, and chemokines, as CXCL10. Vaccines are one of the most striking discoveries in human history that changed dramatically life expectancy. Nonetheless, the occurrence of adverse events and autoimmune phenomena has been described following vaccination, and ITP may represent one of this.Keywords
This publication has 84 references indexed in Scilit:
- In Vivo Platelet Activation in Critically Ill Patients With Primary 2009 Influenza A(H1N1)Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopeniaHaematologica, 2011
- Development of fulminant Type 1 diabetes with thrombocytopenia after influenza vaccination: a case reportDiabetic Medicine, 2011
- Immune thrombocytopenia: No longer ‘idiopathic’Cleveland Clinic Journal of Medicine, 2011
- Association between Drug and Vaccine Use and Acute Immune Thrombocytopenia in ChildhoodDrug Safety, 2010
- Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpuraHaematologica, 2009
- Pathobiology of Secondary Immune ThrombocytopeniaSeminars in Hematology, 2009
- Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpuraBlood, 2008
- Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpuraThrombosis Research, 2007
- T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpuraNature Medicine, 2003